Louisiana Statewide Telehealth & In-Person Care in New Orleans
700 Camp St, Suite 203, New Orleans, LA
Couple sharing a warm, connected moment during the menopausal transition
Intimacy & Pelvic Comfort

Women's Sexual Health During Perimenopause & Menopause

Couple sharing a warm, connected moment during the menopausal transition
The Biological Realities

What Happens to Pelvic & Sexual Tissues

The lower third of the vagina, the urethra, the bladder trigone, and external vulvar structures contain some of the highest concentrations of estrogen and androgen receptors in the female body. When circulating hormone levels drop, these delicate tissues lose moisture, elasticity, blood flow, and protective microflora.

This biological cascade is known as the Genitourinary Syndrome of Menopause (GSM). Unlike hot flashes, which may subside for some women after a few years, GSM is progressive and will worsen over time without localized hormonal intervention.

Desire & Connection

Low Libido: Why It Happens & What We Can Do

Loss of spontaneous sexual desire is one of the most common, yet least-discussed, symptoms among women in their 40s and 50s. It stems from a combination of biological factors:

  • Androgen Deficit: Declining free and total testosterone levels responsible for central nervous system sexual motivation and genital sensation.
  • Anticipatory Pain: When intercourse hurts due to thin vaginal epithelium, the brain instinctively shuts down arousal to protect against physical discomfort.
  • Chronic Sleep Deprivation & Fatigue: Night sweats that fracture REM sleep deplete dopamine and energy stores needed for emotional intimacy.

Our Clinical Protocol for Libido

Care may include vaginal hormones, hormone therapy with estrogen and testosterone based on your symptoms, history, and goals, education and practical strategies to improve comfort, evaluation of urinary and pelvic symptoms, and referral to other specialists when appropriate.

Woman journaling about her wellness and intimacy journey in soft morning light
Pelvic Tissue Changes

Genitourinary Syndrome of Menopause (GSM)

As estrogen and androgen receptors lose their hormonal support, the pelvic floor and urinary tract become vulnerable to three hallmark patterns of GSM. These are not inevitable signs of aging — they are treatable tissue changes.

Vaginal Dryness & Friction

Thinning of vaginal rugae, leading to stinging, burning, chafing, and painful intercourse (dyspareunia).

Recurrent Bladder Infections

Loss of vaginal lactobacilli elevates local pH, allowing E. coli and other bacteria to migrate into the urethra, causing chronic UTIs.

Urinary Urgency & Leaking

Weakening of pelvic floor support tissues and bladder trigone thinning resulting in sudden urgency and stress incontinence.

Evidence-Based, Low-Systemic-Absorption Options

Localized interventions designed to act primarily in pelvic tissues with low systemic absorption.

Localized Vaginal Estrogen (Creams, Tablets, Rings)

Vaginal estrogen stays almost entirely in pelvic tissues, helping regenerate the mucosal lining, restore natural lubrication, and may help reduce recurrent UTIs. Because systemic absorption is very low, it is generally considered a low-risk option by The Menopause Society. Individual response varies.

Compounded Testosterone for Women

Testosterone therapy may be considered for certain patients experiencing changes in sexual desire or response. Treatment is individualized, with potential benefits, risks, and monitoring discussed during clinical evaluation.